B. Mayinger et al., Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker ofGI cancer and dysplastic lesions, GASTROIN EN, 50(2), 1999, pp. 242-246
Background: Dysplasia and early cancer of the upper gastrointestinal (GI) t
ract often are undetected at white-light endoscopy. We describe oral admini
stration of 5-aminolevulinic acid for the in vivo photodynamic diagnosis of
premalignant and malignant lesions during endoscopy.
Methods: Four patients with known gastric adenoma (n = 1), macroscopically
undetected but histologically proven esophageal squamous cell cancer (n = 1
), suspected early cancer of the esophagus (n = I), and multiple duodenal a
denomas (n = 1) were sensitized with 5-aminolevulinic acid administered ora
lly (15 mg/kg body weight). Photodynamic diagnosis was conducted after a re
tention time of 6 to 7 hours with a special light source capable of deliver
ing either white or violet-blue light. Red fluorescence was detected throug
h the gastroscope with an image-intensifying camera. Results: All malignant
lesions exhibited red or bluish fluorescence during photodynamic diagnosis
. Fluorescence-negative mucosal areas proved to be histologically benign.
Conclusion: Fluorescence induced with 5-aminolevulinic acid might be useful
for the endoscopic detection of dysplasia and early carcinoma in the upper
GI tract. Further investigations are needed to evaluate the sensitivity an
d specificity of photodynamic diagnosis for different tumor entities.